Background: Hearing loss (HL) is the leading cause of disability worldwide, with a particularly severe impact on low- and middle-income countries and causing a huge economic burden. While child HL prevention exists, working-age adults (WAP) struggle to avoid occupational and environmental risks.
Method: Using Global Burden of Disease 2021 data, this study analyzed global HL prevalence trends in the WAP (1992-2021). Analyses included age-standardized prevalence rates (ASPR), estimated annual percentage change, and age-period-cohort (APC) modeling, stratified by gender, age, cause, severity, and Social Demographic Index (SDI).
Result: Global WAP HL prevalence significantly increased to 524 million in 2021 (a 56.9% increase since 1992), primarily due to population growth and aging. Age period cohort (APC) analysis revealed different patterns: as age increases, risk increases and cyclical effects generally increased (except in low SDI regions). The upward trend of birth cohorts in high to middle SDI countries was worrying. In addition, this study also observed that there was a gender difference in the prevalence trend of HL in WAP (male incidence rate was higher, but female growth was faster), and the patient population was gradually younger. Improved trends from 2017-2021 globally and regionally suggest a potential, albeit unexpected, positive influence of the COVID-19 pandemic on HL prevalence.
Conclusion: The global HL burden in the WAP is large and uneven, necessitating targeted interventions focusing on modifiable risks and SDI disparities. Further research is essential to understand the trends observed during the COVID-19 pandemic and to improve prevention strategies.
{"title":"Global trends in hearing loss among the working-age population: a 30-year epidemiological analysis.","authors":"Bing-Yu Liang, Ping-Ting Zhou, Zi-Hui Xie, Ke Han, Fen-Fen Li, Zi-Yue Fu, Yan-Xun Han, Shan-Wen Chen, Ye-Hai Liu, Yu-Jie Liu, Qin Wang, Yu-Chen Liu, Bu-Sheng Tong","doi":"10.1080/07853890.2026.2616970","DOIUrl":"10.1080/07853890.2026.2616970","url":null,"abstract":"<p><strong>Background: </strong>Hearing loss (HL) is the leading cause of disability worldwide, with a particularly severe impact on low- and middle-income countries and causing a huge economic burden. While child HL prevention exists, working-age adults (WAP) struggle to avoid occupational and environmental risks.</p><p><strong>Method: </strong>Using Global Burden of Disease 2021 data, this study analyzed global HL prevalence trends in the WAP (1992-2021). Analyses included age-standardized prevalence rates (ASPR), estimated annual percentage change, and age-period-cohort (APC) modeling, stratified by gender, age, cause, severity, and Social Demographic Index (SDI).</p><p><strong>Result: </strong>Global WAP HL prevalence significantly increased to 524 million in 2021 (a 56.9% increase since 1992), primarily due to population growth and aging. Age period cohort (APC) analysis revealed different patterns: as age increases, risk increases and cyclical effects generally increased (except in low SDI regions). The upward trend of birth cohorts in high to middle SDI countries was worrying. In addition, this study also observed that there was a gender difference in the prevalence trend of HL in WAP (male incidence rate was higher, but female growth was faster), and the patient population was gradually younger. Improved trends from 2017-2021 globally and regionally suggest a potential, albeit unexpected, positive influence of the COVID-19 pandemic on HL prevalence.</p><p><strong>Conclusion: </strong>The global HL burden in the WAP is large and uneven, necessitating targeted interventions focusing on modifiable risks and SDI disparities. Further research is essential to understand the trends observed during the COVID-19 pandemic and to improve prevention strategies.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"58 1","pages":"2616970"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objective: </strong>Coagulation dysfunction plays a critical role in the pathogenesis and prognosis of secondary haemophagocytic lymphohistiocytosis (sHLH) in children. This study aims to systematically analyze the coagulation profiles in paediatric sHLH patients, evaluate their prognostic value and provide an effective basis for reducing mortality in children with HLH.</p><p><strong>Methods: </strong>A total of 209 paediatric patients with sHLH were enrolled in this study. Coagulation parameters at admission were collected and compared across groups stratified by aetiology, prognosis and presence of disseminated intravascular coagulation (DIC). The dynamic evolution of coagulation parameters was analyzed using LOWESS curve fitting. LASSO regression was applied to screen for potential risk factors for DIC in sHLH patients, followed by univariate and multivariate logistic regression to identify independent risk factors. Similarly, Kaplan-Meier survival analysis along with univariate and multivariate logistic regression models were used to determine independent risk factors associated with prognosis in sHLH patients.</p><p><strong>Results: </strong>Paediatric patients with secondary haemophagocytic lymphohistiocytosis (sHLH) presented with significant coagulation abnormalities upon hospital admission, as evidenced by markedly elevated prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT) and D-dimer (DD) levels (all <i>p</i> < 0.01). Those with infection-associated HLH demonstrated significantly prolonged PT (<i>p</i> = 0.009), APTT (<i>p</i> < 0.001) and TT (<i>p</i> = 0.0028), along with significantly lower fibrinogen (FIB) levels (<i>p</i> < 0.001), compared to patients with autoimmune-associated HLH. Compared to survivors, deceased HLH patients had significantly higher PT and INR (<i>p</i> < 0.01), as well as significantly elevated DD (<i>p</i> = 0.014). Significant differences were observed in coagulation parameters - PT, INR, APTT, TT, DD, FIB, thrombin-antithrombin complex (TAT) and tissue-type plasminogen activator-inhibitor complex (t-PAIC) - between HLH patients with and without disseminated intravascular coagulation (DIC) (all <i>p</i> < 0.05), and the dynamic changes in these parameters (particularly PT, FIB and DD) also differed notably between the two groups. Neurological involvement, hyper-ferritinaemia and elevated INR were identified as independent risk factors for DIC, while neurological involvement and the presence of DIC itself were independent predictors of mortality in paediatric patients.</p><p><strong>Conclusion: </strong>Coagulation dysfunction serves as a core pathological driver in paediatric sHLH, being especially severe in infection-associated cases. Dynamic monitoring of key coagulation parameters and ferritin levels is crucial for early risk warning and timely intervention. Targeted management of coagulation abnormalities, together with
{"title":"Coagulation dysfunction in children with secondary hemophagocytic lymphohistiocytosis: a comprehensive analysis.","authors":"Chaojun Duan, Qing Liao, Jiale Gong, Xiaofang Bai, Xiangdong Xu, Bo Zhang","doi":"10.1080/07853890.2026.2617724","DOIUrl":"10.1080/07853890.2026.2617724","url":null,"abstract":"<p><strong>Objective: </strong>Coagulation dysfunction plays a critical role in the pathogenesis and prognosis of secondary haemophagocytic lymphohistiocytosis (sHLH) in children. This study aims to systematically analyze the coagulation profiles in paediatric sHLH patients, evaluate their prognostic value and provide an effective basis for reducing mortality in children with HLH.</p><p><strong>Methods: </strong>A total of 209 paediatric patients with sHLH were enrolled in this study. Coagulation parameters at admission were collected and compared across groups stratified by aetiology, prognosis and presence of disseminated intravascular coagulation (DIC). The dynamic evolution of coagulation parameters was analyzed using LOWESS curve fitting. LASSO regression was applied to screen for potential risk factors for DIC in sHLH patients, followed by univariate and multivariate logistic regression to identify independent risk factors. Similarly, Kaplan-Meier survival analysis along with univariate and multivariate logistic regression models were used to determine independent risk factors associated with prognosis in sHLH patients.</p><p><strong>Results: </strong>Paediatric patients with secondary haemophagocytic lymphohistiocytosis (sHLH) presented with significant coagulation abnormalities upon hospital admission, as evidenced by markedly elevated prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT) and D-dimer (DD) levels (all <i>p</i> < 0.01). Those with infection-associated HLH demonstrated significantly prolonged PT (<i>p</i> = 0.009), APTT (<i>p</i> < 0.001) and TT (<i>p</i> = 0.0028), along with significantly lower fibrinogen (FIB) levels (<i>p</i> < 0.001), compared to patients with autoimmune-associated HLH. Compared to survivors, deceased HLH patients had significantly higher PT and INR (<i>p</i> < 0.01), as well as significantly elevated DD (<i>p</i> = 0.014). Significant differences were observed in coagulation parameters - PT, INR, APTT, TT, DD, FIB, thrombin-antithrombin complex (TAT) and tissue-type plasminogen activator-inhibitor complex (t-PAIC) - between HLH patients with and without disseminated intravascular coagulation (DIC) (all <i>p</i> < 0.05), and the dynamic changes in these parameters (particularly PT, FIB and DD) also differed notably between the two groups. Neurological involvement, hyper-ferritinaemia and elevated INR were identified as independent risk factors for DIC, while neurological involvement and the presence of DIC itself were independent predictors of mortality in paediatric patients.</p><p><strong>Conclusion: </strong>Coagulation dysfunction serves as a core pathological driver in paediatric sHLH, being especially severe in infection-associated cases. Dynamic monitoring of key coagulation parameters and ferritin levels is crucial for early risk warning and timely intervention. Targeted management of coagulation abnormalities, together with","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"58 1","pages":"2617724"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-17DOI: 10.1080/07853890.2026.2615482
Verena Zerbato, Benedetta Rossi, Stefano Di Bella, Claudia Bartalucci, Matteo Cerchiaro, Daniele Da Re, Chiara Dentone, Chiara Sepulcri, Giovanni Marini, Emanuele Delfino, Alex Sang Tran, Antonio Di Biagio, Daniele Roberto Giacobbe, Matteo Bassetti
Background: West Nile virus (WNV) is among the most widespread arboviruses and has become a seasonal threat in temperate regions. Sustained in an enzootic bird-mosquito cycle, with humans and horses as incidental hosts, its geographic range has expanded in recent decades due to ongoing climatic and ecological changes. While most infections are asymptomatic or mild, a minority progress to neuroinvasive disease with high morbidity and long-term sequelae. This review summarizes current knowledge on epidemiology, pathogenesis, clinical spectrum, diagnostic challenges, therapeutic options, prevention, and research gaps.
Discussion: Lineages 1 and 2 co-circulate in Europe, where repeated large outbreaks highlight WNV adaptability to warmer summers, altered rainfall, and expanded mosquito habitats driven by recent ecological shifts. After inoculation, replication occurs in keratinocytes and dendritic cells, amplification in lymph nodes, and dissemination to visceral organs and the central nervous system. Neuroinvasion depends on viral proteins and host immune responses. Severe disease is associated with advanced age, immunosuppression, comorbidities, and genetic susceptibility. Clinical manifestations range from febrile illness to meningitis, encephalitis, or acute flaccid myelitis. Persistent neurological and functional sequelae are common, adding to disease burden. Diagnosis relies on molecular and serological tests, limited by short viremia and cross-reactivity with other flaviviruses. No approved antiviral therapy exists; management is supportive. Experimental antivirals, monoclonal antibodies, and interferon have shown mixed results. Vaccine candidates have progressed to phase 1-2 trials, but none are licensed for humans. Prevention relies on integrated vector control, veterinary surveillance, and donor screening, framed within a One Health approach.
Conclusion: WNV exemplifies the impact of global ecological change on zoonotic diseases. Strengthening surveillance, refining diagnostics, and advancing antivirals and vaccines through multidisciplinary collaboration are essential to mitigate future outbreaks.
{"title":"West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions.","authors":"Verena Zerbato, Benedetta Rossi, Stefano Di Bella, Claudia Bartalucci, Matteo Cerchiaro, Daniele Da Re, Chiara Dentone, Chiara Sepulcri, Giovanni Marini, Emanuele Delfino, Alex Sang Tran, Antonio Di Biagio, Daniele Roberto Giacobbe, Matteo Bassetti","doi":"10.1080/07853890.2026.2615482","DOIUrl":"10.1080/07853890.2026.2615482","url":null,"abstract":"<p><strong>Background: </strong>West Nile virus (WNV) is among the most widespread arboviruses and has become a seasonal threat in temperate regions. Sustained in an enzootic bird-mosquito cycle, with humans and horses as incidental hosts, its geographic range has expanded in recent decades due to ongoing climatic and ecological changes. While most infections are asymptomatic or mild, a minority progress to neuroinvasive disease with high morbidity and long-term sequelae. This review summarizes current knowledge on epidemiology, pathogenesis, clinical spectrum, diagnostic challenges, therapeutic options, prevention, and research gaps.</p><p><strong>Discussion: </strong>Lineages 1 and 2 co-circulate in Europe, where repeated large outbreaks highlight WNV adaptability to warmer summers, altered rainfall, and expanded mosquito habitats driven by recent ecological shifts. After inoculation, replication occurs in keratinocytes and dendritic cells, amplification in lymph nodes, and dissemination to visceral organs and the central nervous system. Neuroinvasion depends on viral proteins and host immune responses. Severe disease is associated with advanced age, immunosuppression, comorbidities, and genetic susceptibility. Clinical manifestations range from febrile illness to meningitis, encephalitis, or acute flaccid myelitis. Persistent neurological and functional sequelae are common, adding to disease burden. Diagnosis relies on molecular and serological tests, limited by short viremia and cross-reactivity with other flaviviruses. No approved antiviral therapy exists; management is supportive. Experimental antivirals, monoclonal antibodies, and interferon have shown mixed results. Vaccine candidates have progressed to phase 1-2 trials, but none are licensed for humans. Prevention relies on integrated vector control, veterinary surveillance, and donor screening, framed within a One Health approach.</p><p><strong>Conclusion: </strong>WNV exemplifies the impact of global ecological change on zoonotic diseases. Strengthening surveillance, refining diagnostics, and advancing antivirals and vaccines through multidisciplinary collaboration are essential to mitigate future outbreaks.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"58 1","pages":"2615482"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Transbronchial cryobiopsy (TBCB) is a minimally invasive technique that yields larger specimens than conventional transbronchial forceps biopsies (TBFB) and demonstrates superior diagnostic rates for interstitial lung diseases. However, the efficacy of TBCB compared to TBFB in evaluating peripheral pulmonary lesions (PPLs) is not well established. This study aims to examine the diagnostic performance of TBCB relative to TBFB in PPLs.
Material and methods: Between May 2021 and December 2023, patients with PPLs were enrolled and underwent TBFB followed by TBCB. These procedures were performed either in a hybrid operating room (HOR) or a standard bronchoscopy room without fluoroscopy. The study compared histopathology diagnostic yield between the two methods.
Results: The study included 84 patients. The median lesion size was 37 mm (interquartile range: 26, 54), with 16 lesions (19.0%) measuring less than 2.0 cm. Among the participants, 44 (52.4%) were diagnosed with lung cancer, and 28 (33.3%) had infectious diseases. TBCB yielded significantly larger tissue samples [60 mm3 (range: 30, 144) vs. 4 mm3 (range: 2, 6), p < 0.001] and higher diagnostic yields (94.0% vs. 77.1%, p < 0.001) than TBFB. The higher diagnostic yield for TBCB were consistent in both the bronchoscopic room (97.2% vs. 77.8%, p = 0.008) and HOR (91.5% vs. 76.6%, p = 0.033). The incidence of ≥ grade 3 bleeding was 7.1%.
Conclusion: TBCB significantly improves the diagnostic yield for PPLs, irrespective of fluoroscopic guidance, and is effective for both malignant and benign lesions. Furthermore, it is associated with minimal complications, affirming its safety and efficacy as a diagnostic procedure.HighlightsTBCB consistently provided a higher pathological yield compared to TBFB, independent of lesion size, use of fluoroscopy, or the nature of the pathology (benign or malignant)TBCB yielded larger tissue sample and had high successful rates for NGS testing.Combination of an ultrathin bronchoscope, augmented fluoroscopy, ROSE, and TBCB can lead to high diagnostic yields.
背景:经支气管低温活检(TBCB)是一种微创技术,比传统的经支气管钳活检(TBFB)产生更大的标本,对间质性肺疾病的诊断率更高。然而,与TBFB相比,TBCB在评估周围性肺病变(ppl)方面的疗效尚未得到很好的证实。本研究旨在探讨TBCB相对于TBFB在ppl中的诊断价值。材料和方法:在2021年5月至2023年12月期间,纳入ppl患者并接受TBFB和TBCB。这些手术要么在混合手术室(HOR)进行,要么在没有透视的标准支气管镜室进行。比较了两种方法的组织病理学诊断率。结果:纳入84例患者。病灶大小中位数为37 mm(四分位数间距:26,54),16个(19.0%)病灶尺寸小于2.0 cm。在参与者中,44人(52.4%)被诊断为肺癌,28人(33.3%)患有传染病。TBCB产生了更大的组织样本[60 mm3(范围:30,144)比4 mm3(范围:2,6),p p p = 0.008)和HOR(91.5%比76.6%,p = 0.033)。≥3级出血发生率为7.1%。结论:无论透视指导如何,TBCB均可显著提高ppl的诊断率,对恶性和良性病变均有效。此外,它与最小的并发症相关,肯定了其作为诊断程序的安全性和有效性。与TBFB相比,与病变大小、使用透视或病理性质(良性或恶性)无关,HighlightsTBCB始终提供更高的病理产率。TBCB产生更大的组织样本,并且具有更高的NGS检测成功率。超薄支气管镜、增强透视、ROSE和tbb联合检查可提高诊断率。
{"title":"Comparative study of transbronchial cryobiopsy and transbronchial biopsy for diagnostic yield in peripheral pulmonary lesions.","authors":"Hao-Chun Chang, Ching-Kai Lin, Lun-Che Chen, Ling-Kai Chang, Shun-Mao Yang, Li-Ta Keng, Chong-Jen Yu","doi":"10.1080/07853890.2026.2613456","DOIUrl":"10.1080/07853890.2026.2613456","url":null,"abstract":"<p><strong>Background: </strong>Transbronchial cryobiopsy (TBCB) is a minimally invasive technique that yields larger specimens than conventional transbronchial forceps biopsies (TBFB) and demonstrates superior diagnostic rates for interstitial lung diseases. However, the efficacy of TBCB compared to TBFB in evaluating peripheral pulmonary lesions (PPLs) is not well established. This study aims to examine the diagnostic performance of TBCB relative to TBFB in PPLs.</p><p><strong>Material and methods: </strong>Between May 2021 and December 2023, patients with PPLs were enrolled and underwent TBFB followed by TBCB. These procedures were performed either in a hybrid operating room (HOR) or a standard bronchoscopy room without fluoroscopy. The study compared histopathology diagnostic yield between the two methods.</p><p><strong>Results: </strong>The study included 84 patients. The median lesion size was 37 mm (interquartile range: 26, 54), with 16 lesions (19.0%) measuring less than 2.0 cm. Among the participants, 44 (52.4%) were diagnosed with lung cancer, and 28 (33.3%) had infectious diseases. TBCB yielded significantly larger tissue samples [60 mm<sup>3</sup> (range: 30, 144) vs. 4 mm<sup>3</sup> (range: 2, 6), <i>p</i> < 0.001] and higher diagnostic yields (94.0% vs. 77.1%, <i>p</i> < 0.001) than TBFB. The higher diagnostic yield for TBCB were consistent in both the bronchoscopic room (97.2% vs. 77.8%, <i>p</i> = 0.008) and HOR (91.5% vs. 76.6%, <i>p</i> = 0.033). The incidence of ≥ grade 3 bleeding was 7.1%.</p><p><strong>Conclusion: </strong>TBCB significantly improves the diagnostic yield for PPLs, irrespective of fluoroscopic guidance, and is effective for both malignant and benign lesions. Furthermore, it is associated with minimal complications, affirming its safety and efficacy as a diagnostic procedure.HighlightsTBCB consistently provided a higher pathological yield compared to TBFB, independent of lesion size, use of fluoroscopy, or the nature of the pathology (benign or malignant)TBCB yielded larger tissue sample and had high successful rates for NGS testing.Combination of an ultrathin bronchoscope, augmented fluoroscopy, ROSE, and TBCB can lead to high diagnostic yields.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"58 1","pages":"2613456"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12784633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145936729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Pediatric sepsis represents a significant factor in the mortality rates among children, with survivors remaining highly fragile during the period following discharge. While in-hospital and short-term mortality have been widely studied, the long-term mortality of pediatric sepsis is not adequately synthesized or appreciated. This study aims to estimate the long-term mortality associated with pediatric sepsis, providing a basis for optimizing post-discharge surveillance and care protocols.
Methods: This systematic review and meta-analysis followed PRISMA guidelines and was registered in PROSPERO (CRD420251137504). Exhaustive searches were conducted in PubMed, Embase, the Cochrane Library, and Web of Science for studies published from the inception of each database to June 30, 2025. Studies reporting long-term mortality in pediatric sepsis patients diagnosed using international consensus criteria were included. After literature screening, long-term mortality was pooled using a random effects meta-analysis in R statistical software.
Results: A total of 72,065 records were identified through database searching. After removing duplicates and screening, six studies comprising 11,318 pediatric sepsis patients were included. The pooled long-term mortality in pediatric sepsis was 11% (95% CI: 7-16%), though significant heterogeneity was observed (I2 = 98.2%, p < 0.001). Sensitivity analyses yielded similar results, and evidence of publication bias was limited.
Conclusion: Long-term mortality after pediatric sepsis was 11%, highlighting the persistent risk of mortality after hospital discharge. Further high-quality longitudinal studies are required to identify modifiable risk factors and guide evidence-based follow-up and personalized care.
背景:儿童败血症是儿童死亡率的一个重要因素,幸存者在出院后的一段时间内仍然非常脆弱。虽然住院死亡率和短期死亡率已被广泛研究,但儿童败血症的长期死亡率尚未得到充分的综合或重视。本研究旨在评估儿童脓毒症相关的长期死亡率,为优化出院后监测和护理方案提供依据。方法:本系统评价和荟萃分析遵循PRISMA指南,并在PROSPERO注册(CRD420251137504)。在PubMed、Embase、Cochrane图书馆和Web of Science中进行了详尽的搜索,以获取从每个数据库建立到2025年6月30日发表的研究。研究报告了使用国际共识标准诊断的儿童败血症患者的长期死亡率。在文献筛选后,使用R统计软件进行随机效应荟萃分析,汇总长期死亡率。结果:通过数据库检索,共识别出72065条记录。在剔除重复项和筛选后,纳入了6项研究,包括11318名儿童败血症患者。儿童脓毒症的合并长期死亡率为11% (95% CI: 7-16%),但观察到显著的异质性(I2 = 98.2%, p)。结论:儿童脓毒症的长期死亡率为11%,突出了出院后死亡的持续风险。需要进一步的高质量纵向研究来确定可改变的风险因素,并指导循证随访和个性化护理。
{"title":"Long-term mortality in pediatric sepsis: a systematic review and meta-analysis.","authors":"Yongbiao Lv, Jiayi Zheng, Junxiang Cai, Jingwei Shui, Yuntao Liu, Zhongde Zhang","doi":"10.1080/07853890.2026.2617403","DOIUrl":"10.1080/07853890.2026.2617403","url":null,"abstract":"<p><strong>Background: </strong>Pediatric sepsis represents a significant factor in the mortality rates among children, with survivors remaining highly fragile during the period following discharge. While in-hospital and short-term mortality have been widely studied, the long-term mortality of pediatric sepsis is not adequately synthesized or appreciated. This study aims to estimate the long-term mortality associated with pediatric sepsis, providing a basis for optimizing post-discharge surveillance and care protocols.</p><p><strong>Methods: </strong>This systematic review and meta-analysis followed PRISMA guidelines and was registered in PROSPERO (CRD420251137504). Exhaustive searches were conducted in PubMed, Embase, the Cochrane Library, and Web of Science for studies published from the inception of each database to June 30, 2025. Studies reporting long-term mortality in pediatric sepsis patients diagnosed using international consensus criteria were included. After literature screening, long-term mortality was pooled using a random effects meta-analysis in R statistical software.</p><p><strong>Results: </strong>A total of 72,065 records were identified through database searching. After removing duplicates and screening, six studies comprising 11,318 pediatric sepsis patients were included. The pooled long-term mortality in pediatric sepsis was 11% (95% CI: 7-16%), though significant heterogeneity was observed (<i>I</i><sup>2</sup> = 98.2%, <i>p</i> < 0.001). Sensitivity analyses yielded similar results, and evidence of publication bias was limited.</p><p><strong>Conclusion: </strong>Long-term mortality after pediatric sepsis was 11%, highlighting the persistent risk of mortality after hospital discharge. Further high-quality longitudinal studies are required to identify modifiable risk factors and guide evidence-based follow-up and personalized care.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"58 1","pages":"2617403"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12821344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-09DOI: 10.1080/20565623.2026.2626432
Ghaith B Heilat, Tahani Alwidyan, Amjad Z Alrosan, Aseel O Rataan, Khaled Alrosan, Zuheir R Al Rousan
Objective: To evaluate the awareness and understanding of breast cancer (BC) etiology among Jordanian women and identify associated demographic factors.
Materials and methods: A multiregional cross-sectional survey of 381 women was conducted via online snowball sampling. BC knowledge was assessed using a translated version of the Breast Cancer Awareness Measure. Statistical analyses included univariate and bivariate tests, followed by a multivariate ordinal logistic regression to adjust for potential confounders.
Results: Only 39.9% of participants demonstrated proficient comprehension of BC etiology. Knowledge correlated significantly with age, marital status, and expertise (p < 0.05). Awareness was highest among single pharmacy students; notably, 64.8% were single pharmacy students, potentially inflating overall scores. A misconception was identified: 66.1% believed a diagnosis in one breast reduces risk in the other. Age 41-50 (OR = 5.23) and holding a diploma (OR = 0.09) were significant predictors of knowledge compared to postgraduates, while marital status was not significant in the model.
Conclusions: Educational backgrounds significantly influence breast cancer awareness among Jordanian women. There is an urgent need for targeted, community-based training programs to address persistent clinical misconceptions and knowledge gaps, specifically focusing on married women and individuals working or studying in non-medical fields, to improve overall public health standards nationwide.
{"title":"Understanding breast cancer causes: insights from Jordanian women's awareness.","authors":"Ghaith B Heilat, Tahani Alwidyan, Amjad Z Alrosan, Aseel O Rataan, Khaled Alrosan, Zuheir R Al Rousan","doi":"10.1080/20565623.2026.2626432","DOIUrl":"10.1080/20565623.2026.2626432","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the awareness and understanding of breast cancer (BC) etiology among Jordanian women and identify associated demographic factors.</p><p><strong>Materials and methods: </strong>A multiregional cross-sectional survey of 381 women was conducted via online snowball sampling. BC knowledge was assessed using a translated version of the Breast Cancer Awareness Measure. Statistical analyses included univariate and bivariate tests, followed by a multivariate ordinal logistic regression to adjust for potential confounders.</p><p><strong>Results: </strong>Only 39.9% of participants demonstrated proficient comprehension of BC etiology. Knowledge correlated significantly with age, marital status, and expertise (p < 0.05). Awareness was highest among single pharmacy students; notably, 64.8% were single pharmacy students, potentially inflating overall scores. A misconception was identified: 66.1% believed a diagnosis in one breast reduces risk in the other. Age 41-50 (OR = 5.23) and holding a diploma (OR = 0.09) were significant predictors of knowledge compared to postgraduates, while marital status was not significant in the model.</p><p><strong>Conclusions: </strong>Educational backgrounds significantly influence breast cancer awareness among Jordanian women. There is an urgent need for targeted, community-based training programs to address persistent clinical misconceptions and knowledge gaps, specifically focusing on married women and individuals working or studying in non-medical fields, to improve overall public health standards nationwide.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"12 1","pages":"2626432"},"PeriodicalIF":2.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893684/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-10DOI: 10.1080/07853890.2026.2626224
Chatuthanai Savigamin, Tae Chung, Alison W Rebman, Yanni Larsen, Elizabeth Clark, Erica Cerquetti, Christina Kokorelis, Pegah Dehghan, Peter C Rowe, Brittany L Adler
Background: Postural Orthostatic Tachycardia Syndrome (POTS) and Neurally-Mediated Hypotension (NMH) are heterogeneous syndromes characterized by dysautonomia and multisystem symptoms. Mast cell activation, often manifesting as hives, has been proposed as a contributing mechanism, but its prevalence and clinical relevance in POTS and NMH are poorly defined.
Method: Patients from the Johns Hopkins POTS Clinic completed surveys assessing hives frequency and symptom burden using the Malmö POTS, the Composite Autonomic Symptom Score (COMPASS)-31, and a pain questionnaire. Associations between hives and clinical features were evaluated among patients with confirmed POTS, NMH, or clinically diagnosed orthostatic intolerance.
Result: Among 188 respondents, 80 (42.6%) reported hives sometimes and 33 (17.6%) reported hives often or always. Increasing hives frequency was associated with higher Malmö POTS scores and greater autonomic symptom burden across multiple COMPASS-31 subdomains, including gastrointestinal, bladder, and vasomotor symptoms (all p < 0.05). Hives was also associated with pain (OR 3.47, 95% CI 1.54-7.77, p = 0.002) and tingling (OR 5.73, CI 2.15-15.26, p < 0.001), but not orthostatic symptoms. These associations persisted after multivariable adjustment.
Conclusion: Hives are common in orthostatic intolerance syndromes and are associated with increased symptom burden. Future studies are needed to clarify the role of mast cell activation and evaluate mast cell-targeted therapies.
背景:体位性站立性心动过速综合征(POTS)和神经介导性低血压(NMH)是异质性综合征,以自主神经异常和多系统症状为特征。肥大细胞活化,通常表现为荨麻疹,被认为是一种促进机制,但其在POTS和NMH中的患病率和临床相关性尚不明确。方法:来自约翰霍普金斯POTS诊所的患者使用Malmö POTS、复合自主症状评分(COMPASS)-31和疼痛问卷完成调查,评估荨麻疹频率和症状负担。在确诊为POTS、NMH或临床诊断为直立不耐受的患者中,评估了荨麻疹与临床特征之间的关系。结果:188名被调查者中,有80人(42.6%)报告有时有荨麻疹,33人(17.6%)报告经常或总是有荨麻疹。增加荨麻疹频率与更高的Malmö POTS评分和更大的自主神经症状负担相关,包括胃肠道、膀胱和血管舒张症状(所有p p = 0.002)和刺痛(OR 5.73, CI 2.15-15.26, p)。结论:荨麻疹常见于直立性不耐受综合征,并与症状负担增加相关。未来的研究需要明确肥大细胞活化的作用,并评估肥大细胞靶向治疗。
{"title":"Hives in autonomic disorders: a cutaneous marker of a distinct symptom phenotype.","authors":"Chatuthanai Savigamin, Tae Chung, Alison W Rebman, Yanni Larsen, Elizabeth Clark, Erica Cerquetti, Christina Kokorelis, Pegah Dehghan, Peter C Rowe, Brittany L Adler","doi":"10.1080/07853890.2026.2626224","DOIUrl":"10.1080/07853890.2026.2626224","url":null,"abstract":"<p><strong>Background: </strong>Postural Orthostatic Tachycardia Syndrome (POTS) and Neurally-Mediated Hypotension (NMH) are heterogeneous syndromes characterized by dysautonomia and multisystem symptoms. Mast cell activation, often manifesting as hives, has been proposed as a contributing mechanism, but its prevalence and clinical relevance in POTS and NMH are poorly defined.</p><p><strong>Method: </strong>Patients from the Johns Hopkins POTS Clinic completed surveys assessing hives frequency and symptom burden using the Malmö POTS, the Composite Autonomic Symptom Score (COMPASS)-31, and a pain questionnaire. Associations between hives and clinical features were evaluated among patients with confirmed POTS, NMH, or clinically diagnosed orthostatic intolerance.</p><p><strong>Result: </strong>Among 188 respondents, 80 (42.6%) reported hives sometimes and 33 (17.6%) reported hives often or always. Increasing hives frequency was associated with higher Malmö POTS scores and greater autonomic symptom burden across multiple COMPASS-31 subdomains, including gastrointestinal, bladder, and vasomotor symptoms (all <i>p</i> < 0.05). Hives was also associated with pain (OR 3.47, 95% CI 1.54-7.77, <i>p</i> = 0.002) and tingling (OR 5.73, CI 2.15-15.26, <i>p</i> < 0.001), but not orthostatic symptoms. These associations persisted after multivariable adjustment.</p><p><strong>Conclusion: </strong>Hives are common in orthostatic intolerance syndromes and are associated with increased symptom burden. Future studies are needed to clarify the role of mast cell activation and evaluate mast cell-targeted therapies.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"58 1","pages":"2626224"},"PeriodicalIF":4.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146159686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2025-12-12DOI: 10.1080/20565623.2025.2601632
Hadeel Heilat, Shuja Mashagba, Mosab Said, Ronza Nemrawi, Fadi Alkhawaja, Eman Al-Refai, Mohammad AlElaimat, Saleh Bani Nassr, Dima Oudat
Background: Body shape concerns (BSC) and body dissatisfaction represent emerging public health issues, yet evidence from Middle Eastern contexts, including Jordan, remains limited. These concerns adversely affect psychological health and are shaped by sociocultural pressures and digital media exposure.
Methods: A cross-sectional study was conducted among 418 undergraduate university students in Northern Jordan. Participants completed the Body Shape Questionnaire-8D (BSQ-8D) to assess BSC. Demographic, behavioral, and media use variables were analyzed to identify correlations.
Results: Among 418 respondents (96% aged 17-24; 53% female), 73% reported no BSC. Higher levels of BSC were significantly associated with increased body mass index (BMI) (p < 0.001). Compared to normal-weight peers, overweight students had higher odds of reporting mild [adjusted odds ratio (AOR: 3.7)]and moderate to marked (AOR: 2.56) BSC. Parental education and social media use were also significant factors. Students who did not use Snapchat (AOR = 2.05), did not use TikTok (AOR = 2.15), and cigarette smokers (AOR = 2.75) had higher odds of reporting elevated BSC levels.
Conclusions: BSC among Jordanian university students is shaped by multiple psychosocial and behavioral factors, with BMI emerging as the strongest predictor. Findings underscore the need for culturally informed strategies addressing weight stigma, smoking, parental influences, and media engagement. Integrating BSC screening into routine healthcare may support early detection of at-risk groups.
{"title":"Body shape concerns among Jordanian university students: prevalence, correlates, and association with social media use.","authors":"Hadeel Heilat, Shuja Mashagba, Mosab Said, Ronza Nemrawi, Fadi Alkhawaja, Eman Al-Refai, Mohammad AlElaimat, Saleh Bani Nassr, Dima Oudat","doi":"10.1080/20565623.2025.2601632","DOIUrl":"10.1080/20565623.2025.2601632","url":null,"abstract":"<p><strong>Background: </strong>Body shape concerns (BSC) and body dissatisfaction represent emerging public health issues, yet evidence from Middle Eastern contexts, including Jordan, remains limited. These concerns adversely affect psychological health and are shaped by sociocultural pressures and digital media exposure.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 418 undergraduate university students in Northern Jordan. Participants completed the Body Shape Questionnaire-8D (BSQ-8D) to assess BSC. Demographic, behavioral, and media use variables were analyzed to identify correlations.</p><p><strong>Results: </strong>Among 418 respondents (96% aged 17-24; 53% female), 73% reported no BSC. Higher levels of BSC were significantly associated with increased body mass index (BMI) (<i>p</i> < 0.001). Compared to normal-weight peers, overweight students had higher odds of reporting mild [adjusted odds ratio (AOR: 3.7)]and moderate to marked (AOR: 2.56) BSC. Parental education and social media use were also significant factors. Students who did not use Snapchat (AOR = 2.05), did not use TikTok (AOR = 2.15), and cigarette smokers (AOR = 2.75) had higher odds of reporting elevated BSC levels.</p><p><strong>Conclusions: </strong>BSC among Jordanian university students is shaped by multiple psychosocial and behavioral factors, with BMI emerging as the strongest predictor. Findings underscore the need for culturally informed strategies addressing weight stigma, smoking, parental influences, and media engagement. Integrating BSC screening into routine healthcare may support early detection of at-risk groups.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"12 1","pages":"2601632"},"PeriodicalIF":2.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2025-12-23DOI: 10.1080/19336950.2025.2602975
Edward Mendez-Otalvaro, Wojciech Kopec, Marcus Schewe, Bert L de Groot
The modulator pocket is a cryptic site discovered in the TREK1 (K2P2.1) K2P channel. This pocket, located close to the selectivity filter, accommodates agonists that enhance the channel's activity. Since its discovery, equivalent sites in other K2P channels have been shown to bind various ligands, both endogenous and exogenous. In this review, we attempt to elucidate how the modulator pocket contributes to K2P channel activation. To this end, we first describe the gating mechanisms reported in the literature and rationalize their modes of action. We then highlight previous experimental and computational evidence for agonists that bind to the modulator pocket, together with mutations at this site that affect gating. Finally, we elaborate how the activation signal arising from the modulator pocket is transduced to the gates in K2P channels. In doing so, we outline a potential common modulator pocket architecture across K2P channels: a largely amphipathic structure - consistent with the expected properties of a pocket exposed at the interface between a hydrophobic membrane and the aqueous solvent - but still with some important channel-sequence-variations. This architecture and its key differences can be leveraged for the design of new selective and potent modulators.
{"title":"One pocket to activate them all (?): Efforts on understanding the modulator pocket in K2P channels.","authors":"Edward Mendez-Otalvaro, Wojciech Kopec, Marcus Schewe, Bert L de Groot","doi":"10.1080/19336950.2025.2602975","DOIUrl":"10.1080/19336950.2025.2602975","url":null,"abstract":"<p><p>The modulator pocket is a cryptic site discovered in the TREK1 (K<sub>2P</sub>2.1) K2P channel. This pocket, located close to the selectivity filter, accommodates agonists that enhance the channel's activity. Since its discovery, equivalent sites in other K2P channels have been shown to bind various ligands, both endogenous and exogenous. In this review, we attempt to elucidate how the modulator pocket contributes to K2P channel activation. To this end, we first describe the gating mechanisms reported in the literature and rationalize their modes of action. We then highlight previous experimental and computational evidence for agonists that bind to the modulator pocket, together with mutations at this site that affect gating. Finally, we elaborate how the activation signal arising from the modulator pocket is transduced to the gates in K2P channels. In doing so, we outline a potential common modulator pocket architecture across K2P channels: a largely amphipathic structure - consistent with the expected properties of a pocket exposed at the interface between a hydrophobic membrane and the aqueous solvent - but still with some important channel-sequence-variations. This architecture and its key differences can be leveraged for the design of new selective and potent modulators.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":"20 1","pages":"2602975"},"PeriodicalIF":3.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12758241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145822239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-05DOI: 10.1080/19491034.2025.2611484
Sandra Vidak, Sohyoung Kim, Tom Misteli
Hutchinson Gilford Progeria Syndrome (HGPS) is an ultra-rare pediatric premature aging disorder. It is caused by a point mutation in the LMNA gene leading to the production of the dominant-negative progerin isoform of the nuclear envelope protein lamin A. Most of the mechanistic insights into the disease have come from studies using cellular or mouse models of HGPS. To probe the clinical relevance of previously implicated cellular pathways and to address the extent of gene expression heterogeneity between patients, we performed transcriptomic analysis of a comprehensive set of HGPS patients. We find misexpression of several cellular pathways, including multiple signaling pathways, the Unfolded Protein Response (UPR) and mesodermal cell fate specification. Variability amongst individual patients was limited, with misregulation of the major pathways observed in most patients. Comparing the transcriptome of patients with an inducible HGPS cell model, we also identified the primary target pathways of the disease-causing progerin protein.
{"title":"Transcriptional profiling of Hutchinson-Gilford progeria patients identifies primary target pathways of progerin.","authors":"Sandra Vidak, Sohyoung Kim, Tom Misteli","doi":"10.1080/19491034.2025.2611484","DOIUrl":"10.1080/19491034.2025.2611484","url":null,"abstract":"<p><p>Hutchinson Gilford Progeria Syndrome (HGPS) is an ultra-rare pediatric premature aging disorder. It is caused by a point mutation in the <i>LMNA</i> gene leading to the production of the dominant-negative progerin isoform of the nuclear envelope protein lamin A. Most of the mechanistic insights into the disease have come from studies using cellular or mouse models of HGPS. To probe the clinical relevance of previously implicated cellular pathways and to address the extent of gene expression heterogeneity between patients, we performed transcriptomic analysis of a comprehensive set of HGPS patients. We find misexpression of several cellular pathways, including multiple signaling pathways, the Unfolded Protein Response (UPR) and mesodermal cell fate specification. Variability amongst individual patients was limited, with misregulation of the major pathways observed in most patients. Comparing the transcriptome of patients with an inducible HGPS cell model, we also identified the primary target pathways of the disease-causing progerin protein.</p>","PeriodicalId":74323,"journal":{"name":"Nucleus (Austin, Tex.)","volume":"17 1","pages":"2611484"},"PeriodicalIF":4.5,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12773485/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}